We further compared the status of CDMs between the circulating T cells derived from PBMCs and tumor-infiltrating T cells, and results showed that enhancement of cuproptosis is observed in CD4+ T, CD8+ T and Tprolif that derived from PBMCs of patients (Figure 3D). The gene discussed is CD4; the disease is neoplasm.